Issue link: https://viewer.e-digitaledition.com/i/459868
CONTINUED FROM PAGE 8 IMPORTANT IMPLICATIONS FOR RESEARCH AND PEOPLE The results of this research are an important new tool to advance the field of Down syndrome research. Dr. Lawrence's new preliminary data indicates that the most significant changes may not be in the activity of genes on chromosome 21, as many researchers still suspect, but rather are on many other chromosomes. This suggests that health or cognition problems associated with Down syndrome may be a result of how the extra chromosome regulates gene activity on other chromosomes versus just chromosome 21. "Muting the chromosome enables all types of research and helps us understand how the extra chromosome causes health effects in those with Down syndrome," Dr. Blumenthal said. "If you use Dr. Lawrence's method to mute the extra chromosome, you can compare two populations of cells that are otherwise identical except for the third copy of chromosome 21. Previously, we had no way of doing this except with studies of twins." Dr. Lawrence and other researchers are still exploring all the ways chromosome silencing can help advance research into some of the medical issues associated with Down syndrome, as well as other chromosomal conditions. For example, Dr. Lawrence's other research focuses on the prevalence of Alzheimer's disease in patients with Down syndrome. Researchers could compare how neurons affected by Down syndrome and unaffected by Down syndrome develop and gain a better understanding of exactly what is different about those two groups of cells. The next step would be to understand any connection between the cells' differences and the increased prevalence of Alzheimer's disease in those with Down syndrome. Dr. Lawrence is a brilliant researcher but also a humanist with the goal of helping people. This is good news for people with any trisomic condition, including those with Down syndrome. "Years ago, I met a young adult with Down syndrome and we became close friends," Dr. Lawrence said. "My desire is to see my work actually improving the quality of life of these amazing individuals." To learn more about ongoing research about Down syndrome, visit globaldownsyndrome.org/research-medical-care. SCIENCE SNPS Continued "Dr. Lawrence was able to harness the power of something that already happens in our genetic code on chromosome X and use it to mute trisomy 21 at a cellular level. This is truly game-changing." — TOM BLUMENTHAL, PH.D., EXECUTIVE DIRECTOR OF THE LINDA CRNIC INSTITUTE FOR DOWN SYNDROME result in an approximately three-fold reduction in RSV-related hospitalization in children who have Down syndrome. Researchers say the results need to be replicated in further study. Pediatrics, 2014 COMPOUND MAY BOOST BRAIN GROWTH The cerebellum — the area of the brain responsible for balance and coordinated movement — is approximately 60 percent smaller in individuals with Down syndrome. Researchers from Johns Hopkins University and the National Institutes of Health injected a molecule known as SAG 1.1 into newborn mice with Down syndrome to see if it stimulated cerebral development. Mice that received the injection had a typical-size cerebellum at adulthood. These mice also performed better on the Morris water-maze task than mice that didn't get treatment, indicating possible improvements in learning and memory. Researchers are planning further study to see if a similar therapy can be developed for children with Down syndrome. Science Translational Medicine, 2013; Nature Genetics, 2013 A 50-YEAR JOURNEY When Janet Carr, Ph.D., a UK-based researcher, began studying the educational needs of 54 six-week-old babies with Down syndrome and 54 typical babies in November 1964, she had no idea her life's work would be devoted to understanding Down syndrome and eliminating related stigmas. But that's exactly what happened when a 10-month research project evolved into an astonishing 50-year odyssey chronicling the impact of Down syndrome on individuals and families. Throughout her career, Dr. Carr has published more than 60 articles and textbook chapters, as well as a book, Down's Syndrome: Children Growing Up, which discuss the children's development at various points throughout childhood and adulthood. Though she formally retired in 1992, Dr. Carr has continued her work and is now completing the final paper in her study. This paper will touch on topics related to Down syndrome and aging, which the children are now facing as they celebrate their 50th birthdays. WINTER2015 DOWN SYNDROME WORLD 10

